Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual Biologic or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease (DOUBLE-PIBD): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN
Anat Yerushalmy‐Feler, Christine Olbjørn, Kaija‐Leena Kolho, et al.
Inflammatory Bowel Diseases (2023)
Closed Access | Times Cited: 19

Showing 19 citing articles:

Efficacy and safety of dual-targeted therapy for inflammatory bowel disease: a retrospective multicenter study in China
Xin Jin, Kefang Sun, Liying Wang, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access | Times Cited: 2
Combination biologic therapy in pediatric inflammatory bowel disease: Safety and efficacy over a minimum 12‐month follow‐up period
Magdalena Wlazło, Monika Meglicka, Anna Wiernicka, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024) Vol. 79, Iss. 1, pp. 54-61
Closed Access | Times Cited: 5
Dual Biologic or Small Molecule Therapy in Pediatric Inflammatory Bowel Disease: A Single Center Experience
Guo Cheng, Jin Zhou, Guoli Wang, et al.
Children (2025) Vol. 12, Iss. 1, pp. 75-75
Open Access
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study
Shlomi Cohen, Elizabeth Spencer, Michael Dolinger, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access
Positionspapier der Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE) zum zulassungsüberschreitenden Gebrauch von für Erwachsene mit CED zugelassenen Biologika und Signalinhibitoren bei Kindern und Jugendlichen
Jan Däbritz, Martin Claßen, K. Krohn, et al.
Zeitschrift für Gastroenterologie (2025)
Open Access
Daily Vitamin D3 Versus Stoss Vitamin D3 for Correction of 25OHD Deficiency in Children with Inflammatory Bowel Disease, a Randomised Controlled Trial
Jonathan O'Donnell, Steven T. Leach, Nerissa L. Bowcock, et al.
Digestive Diseases and Sciences (2025)
Open Access
Safety of Advanced Combination Treatment With Selective JAK1 Inhibitors and Biological Therapies in Inflammatory Bowel Diseases: A Real World Experience
C. Cussac, Pauline Rivière, Romain Altwegg, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access
Comparative Effectiveness of Dual Biologic Therapy and Biologic Small‐Molecule Therapy for Refractory Inflammatory Bowel Disease: A Retrospective Single‐Center Study
Fan Yin, Xiaolei Liu, Dongdong He, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 3
Open Access
Real-World Outcomes of Dual Advanced Therapy in Children and Young Adults with Inflammatory Bowel Disease
Amelia Kellar, Michael Dolinger, Elizabeth Spencer, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 5, pp. 1826-1833
Closed Access | Times Cited: 4
Dual biological therapy and small molecules in pediatric inflammatory bowel disease
Francesca Penagini, Luisa Lonoce, Luisa Abbattista, et al.
Pharmacological Research (2023) Vol. 196, pp. 106935-106935
Open Access | Times Cited: 9
A practical guide to combination advanced therapy in inflammatory bowel disease
Christina M. Ray, Remo Panaccione, Christopher Ma
Current Opinion in Gastroenterology (2024) Vol. 40, Iss. 4, pp. 251-257
Closed Access | Times Cited: 2
Advancements in the management of pediatric inflammatory bowel disease
Jonathan O'Donnell, Sonia Thomas, Eric I. Benchimol
Expert Review of Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 1
Challenges in IBD Research 2024: Pragmatic Clinical Research
Jessica R. Allegretti, Liliana Bordeianou, Oriana M. Damas, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. Supplement_2, pp. S55-S66
Open Access | Times Cited: 1
Dual-Targeted Therapy in Pediatric Inflammatory Bowel Disease: A Comprehensive Review
Anat Yerushalmy‐Feler, Caroline Brauner, Shlomi Cohen
Pediatric Drugs (2023) Vol. 25, Iss. 5, pp. 489-498
Closed Access | Times Cited: 3
Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative
Nassim Hammoudi, Déborah Hassid, Joëlle Bonnet, et al.
Scandinavian Journal of Gastroenterology (2024) Vol. 59, Iss. 5, pp. 553-560
Closed Access
Considerations in Paediatric and Adolescent Inflammatory Bowel Disease
S Vuijk, A Camman, Lissy de Ridder
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. Supplement_2, pp. ii31-ii45
Open Access
Updates In The Management Of Pediatric Inflammatory Bowel Disease
Nicholas Carman
Canadian IBD Today (2024)
Open Access
Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents
Omar I. Saadah, Turki AlAmeel, Ahmed Al Sarkhy, et al.
Saudi Journal of Gastroenterology (2024)
Open Access
Biologics in the management of pediatric inflammatory bowel disease: When and what to choose
Arghya Samanta, Anshu Srivastava
World Journal of Clinical Pediatrics (2024) Vol. 14, Iss. 1
Closed Access
Page 1

Scroll to top